Average Co-Inventor Count = 4.07
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Serono S. A. (10 from 145 patents)
2. Iteos Therapeutics (7 from 7 patents)
3. Pfizer Corporation (3 from 4,455 patents)
4. Ares Trading S.a. (2 from 135 patents)
5. Iteos Belgium Sa (2 from 3 patents)
6. Other (1 from 832,680 patents)
7. Merck Patent Gmbh (1 from 2,937 patents)
23 patents:
1. 11427594 - Non brain penetrant A2A inhibitors and methods for use in the treatment of cancers
2. 11376255 - Thiocarbamate derivatives as A2A inhibitors, pharmaceutical composition thereof and combinations with anticancer agents
3. 10945994 - Combinations comprising a pyrrolidine-2,5-dione IDO1 inhibitor and an anti-body
4. 10544095 - 3-indol substituted derivatives, pharmaceutical compositions and methods for use
5. 10398679 - Treatment method utilizing pyrrolidine-2, 5-dione derivatives as IDO1 inhibitors
6. 9949951 - Pyrrolidine-2, 5-dione derivatives, pharmaceutical compositions and methods for use as IDO1 inhibitors
7. 9873690 - 3-indol substituted derivatives, pharmaceutical compositions and methods for use
8. 9758505 - 3-(indol-3-yl)-pyridine derivatives, pharmaceutical compositions and methods for use
9. 9688702 - Alpha-amino boronic acid derivatives, selective immunoproteasome inhibitors
10. 9603836 - Pyrrolidine-2, 5-dione derivatives, pharmaceutical compositions and methods for use as IDO1 inhibitors
11. 9567320 - Pyridazinone-amides derivatives
12. 9216991 - Pyrimidine pyrazolyl derivatives
13. 9150519 - 6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (S1P) receptor for the treatment of multiple sclerosis
14. 9126984 - 4-(indol-3-yl)-pyrazole derivatives, pharmaceutical compositions and methods for use
15. 9073892 - Indazolyl triazol derivatives